Reply to SGLT-2 inhibitors: Post-infarction interventional effects
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Pharmacological Research - 189(2023), Seite 106664- Zur Gesamtaufnahme - volume:189 |
---|
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Pasquale Paolisso [VerfasserIn] |
---|
Links: |
doi.org [kostenfrei] |
---|
Themen: |
---|
doi: |
10.1016/j.phrs.2023.106664 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
DOAJ100946852 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | DOAJ100946852 | ||
003 | DE-627 | ||
005 | 20240414141120.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240414s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.phrs.2023.106664 |2 doi | |
035 | |a (DE-627)DOAJ100946852 | ||
035 | |a (DE-599)DOAJc3cf72e7b8574a6899f3e5de9d42934b | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
050 | 0 | |a RM1-950 | |
100 | 0 | |a Pasquale Paolisso |e verfasserin |4 aut | |
245 | 1 | 0 | |a Reply to SGLT-2 inhibitors: Post-infarction interventional effects |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
653 | 0 | |a Therapeutics. Pharmacology | |
700 | 0 | |a Luca Bergamaschi |e verfasserin |4 aut | |
700 | 0 | |a Felice Gragnano |e verfasserin |4 aut | |
700 | 0 | |a Emanuele Gallinoro |e verfasserin |4 aut | |
700 | 0 | |a Arturo Cesaro |e verfasserin |4 aut | |
700 | 0 | |a Celestino Sardu |e verfasserin |4 aut | |
700 | 0 | |a Niya Mileva |e verfasserin |4 aut | |
700 | 0 | |a Alberto Foà |e verfasserin |4 aut | |
700 | 0 | |a Matteo Armillotta |e verfasserin |4 aut | |
700 | 0 | |a Angelo Sansonetti |e verfasserin |4 aut | |
700 | 0 | |a Sara Amicone |e verfasserin |4 aut | |
700 | 0 | |a Andrea Impellizzeri |e verfasserin |4 aut | |
700 | 0 | |a Giuseppe Esposito |e verfasserin |4 aut | |
700 | 0 | |a Nuccia Morici |e verfasserin |4 aut | |
700 | 0 | |a Oreglia Jacopo Andrea |e verfasserin |4 aut | |
700 | 0 | |a Gianni Casella |e verfasserin |4 aut | |
700 | 0 | |a Ciro Mauro |e verfasserin |4 aut | |
700 | 0 | |a Dobrin Vassilev |e verfasserin |4 aut | |
700 | 0 | |a Nazzareno Galie |e verfasserin |4 aut | |
700 | 0 | |a Gaetano Santulli |e verfasserin |4 aut | |
700 | 0 | |a Raffaele Marfella |e verfasserin |4 aut | |
700 | 0 | |a Paolo Calabrò |e verfasserin |4 aut | |
700 | 0 | |a Emanuele Barbato |e verfasserin |4 aut | |
700 | 0 | |a Carmine Pizzi |e verfasserin |4 aut | |
773 | 0 | 8 | |i In |t Pharmacological Research |g 189(2023), Seite 106664- |
773 | 1 | 8 | |g volume:189 |g year:2023 |g pages:106664- |
856 | 4 | 0 | |u https://doi.org/10.1016/j.phrs.2023.106664 |z kostenfrei |
856 | 4 | 0 | |u https://doaj.org/article/c3cf72e7b8574a6899f3e5de9d42934b |z kostenfrei |
856 | 4 | 0 | |u http://www.sciencedirect.com/science/article/pii/S1043661823000208 |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/1096-1186 |y Journal toc |z kostenfrei |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_DOAJ | ||
951 | |a AR | ||
952 | |d 189 |j 2023 |h 106664- |